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Cosegregation of profound, congenital deafness with markers on chromosome 6q13 in three Pakistani families
defines a new recessive deafness locus, DFNB37. Haplotype analyses reveal a 6-cM linkage region, flanked by
markers D6S1282 and D6S1031, that includes the gene encoding unconventional myosin VI. In families with
recessively inherited deafness, DFNB37, our sequence analyses ofMYO6 reveal a frameshift mutation (36-37insT),
a nonsense mutation (R1166X), and a missense mutation (E216V). These mutations, along with a previously
published missense allele linked to autosomal dominant progressive hearing loss (DFNA22), provide an allelic
spectrum that probes the relationship between myosin VI dysfunction and the resulting phenotype.
Autosomal recessive deafness is a genetically heteroge-
neous neurosensory disorder for which 54 distinct loci
have been published and 32 genes have been identified
(Petit et al. 2001; Griffith and Friedman 2002). Most
autosomal recessive deafness is clinically indistinguish-
able, so genetic loci are most often identified by linkage
studies using large, usually consanguineous pedigrees
(Friedman et al. 2000). We ascertained a large Pakistani
family, PKDF10 (fig. 1), with six individuals who have
bilateral, profound, sensorineural, congenital hearing loss
segregating as an autosomal recessive disorder. In addition
to deafness, vestibular dysfunction and mild facial dys-
morphology also occur in this family. One hearing-im-
paired individual (IV:19; table 1) has retinitis pigmentosa
(RP) along with a vestibular abnormality. The latter two
signs, when co-occuring with deafness, constitute Usher
syndrome, which is also genetically heterogeneous (He-
reditary Hearing Loss Homepage). However, the other
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clinical phenotypes were mild and did not occur in all
deaf individuals (table 1).
A new autosomal recessive deafness locus, DFNB37,
was defined in family PKDF10, by virtue of exclusion of
linkage of the deafness phenotype to markers linked to
known DFNB loci. A genomewide scan using the Weber
9 marker panel revealed cosegregation with markers at
6q13 (LOD score [Z] 7.10 for D6S1589, at a recombi-
nation fraction [v] of 0; see table 2). Haplotype analysis
defined a proximal recombination at marker D6S1282
(82.59 cM) in affected individual IV:17 and a distal re-
combination in individual IV:15, who has normal hearing
and is homozygous for marker D6S460 (89.63 cM) (fig.
1). Markers in the DFNB37 interval were used to screen
250 Pakistani and 100 Indian families segregating reces-
sive deafness. Two additional families withDFNB37 link-
age were identified, PKDF71 and PKSR14 (fig. 1; table
2). Affected individuals from family PKDF71 have pro-
found sensorineural hearing loss, and the affected indi-
vidual from family PKSR14 has severe-to-profound hear-
ing loss. There were no obvious clinically relevant traits
segregating in the families, other than deafness.Haplotype
analysis of affected individual IV:10 from family PKDF71
defined a distal recombination breakpoint, reducing the
linkage region forDFNB37 to ∼6 cM, bounded by mark-
ers D6S1282 (82.59 cM) and D6S1031 (88.63 cM) (fig.
Figure 1 Haplotypes of markers showing linkage to DFNB37 at 6q13 for three families segregating profound, sensorineural, recessive
hearing loss. Affected individual IV:17 in family PKDF10 provided the proximal recombination breakpoint at marker D6S1282 (82.59 cM).
The distal recombination is provided by affected individual IV:10 of family PKDF71 at marker D6S1031 (88.63 cM). National Institutes of
Health (OH93-N-016) and National Centre of Excellence inMolecular Biology (CEMB) institutional review board approval andwritten informed
consent were obtained from all participating subjects. DNA was extracted from either peripheral blood samples or buccal swabs and was
amplified using fluorescent-labeled primers for STR markers linked to reported nonsyndromic recessive deafness (DFNB) loci. Amplimers were
visualized by gel electrophoresis on ABI 377 DNA sequencers, and genotypes were determined using Genescan and Genotyper software (Applied
Biosystems). The genetic linkage distances are from the Center for Medical Genetics Web server.
Ta
bl
e
1
C
lin
ic
al
D
es
cr
ip
ti
on
of
PK
D
F1
0
SU
B
JE
C
T
a
A
G
E
(y
ea
rs
)
H
E
A
R
IN
G
PH
E
N
O
T
Y
P
E
V
E
ST
IB
U
L
A
R
PH
E
N
O
T
Y
P
E
E
Y
E
PH
E
N
O
T
Y
P
E
O
T
H
E
R
FI
N
D
IN
G
S
A
ge
at
A
m
bu
la
ti
on
E
N
G
R
es
ul
ts
Fu
nd
os
co
py
R
es
ul
ts
E
R
G
R
es
ul
ts
IV
:1
6
20
Pr
of
ou
nd
he
ar
in
g
lo
ss
6
ye
ar
s
A
bn
or
m
al
C
on
ge
ni
ta
l
st
at
io
na
ry
ni
gh
t
bl
in
dn
es
s
N
or
m
al
R
et
in
al
pi
gm
en
t
ep
it
he
lia
l
ch
an
ge
s;
fla
t
fe
et
an
d
pr
om
in
en
ce
of
th
e
ta
lu
s
du
e
to
la
ck
of
ar
ch
es
in
th
e
fe
et
;
at
ro
ph
y
of
th
e
m
us
cl
es
ar
ou
nd
th
e
A
ch
ill
es
te
nd
on
;
m
in
or
fa
ci
al
dy
sm
or
ph
ic
fe
at
ur
es
IV
:1
7
9
Pr
of
ou
nd
he
ar
in
g
lo
ss
14
m
o
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
or
m
al
H
is
to
ry
of
hy
st
er
ic
fit
s
fr
om
th
e
ag
e
of
1
m
o;
fla
t
fe
et
an
d
pr
om
in
en
ce
of
ta
lu
s
du
e
to
la
ck
of
ar
ch
es
in
th
e
fe
et
;
m
in
or
fa
ci
al
dy
sm
or
ph
ic
fe
at
ur
es
;
lo
rd
ot
ic
po
st
ur
e
bu
t
no
m
us
cu
la
r
w
ea
kn
es
s
IV
:1
9
10
Pr
of
ou
nd
he
ar
in
g
lo
ss
15
m
o
N
A
R
P
R
P
A
lt
er
na
ti
ng
sq
ui
nt
;
di
ffi
cu
lt
ie
s
in
ta
nd
em
ga
it
IV
:2
0
16
Pr
of
ou
nd
he
ar
in
g
lo
ss
18
m
o
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
or
m
al
H
is
to
ry
of
hy
st
er
ic
fit
s
fr
om
th
e
ag
e
of
1
m
o;
al
te
rn
at
in
g
sq
ui
nt
IV
:8
13
Pr
of
ou
nd
he
ar
in
g
lo
ss
18
m
o
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
or
m
al
A
lt
er
na
ti
ng
sq
ui
nt
;
fla
t
fe
et
an
d
pr
om
in
en
ce
of
ta
lu
s
du
e
to
la
ck
of
ar
ch
es
in
th
e
fe
et
IV
:2
18
Pr
of
ou
nd
he
ar
in
g
lo
ss
30
m
o
A
bn
or
m
al
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
A
IV
:2
3
17
N
or
m
al
3
ye
ar
s
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
A
W
ea
kn
es
s
in
th
e
ri
gh
t
le
g
IV
:2
2
11
N
or
m
al
15
m
o
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
A
IV
:1
8
24
N
or
m
al
18
m
o
N
A
N
o
ab
no
rm
al
it
y
de
te
ct
ed
N
A
N
O
T
E
.—
E
N
G
p
el
ec
tr
on
ys
ta
gm
og
ra
ph
y;
E
R
G
p
el
ec
tr
or
et
in
og
ra
ph
y;
N
A
p
no
t
av
ai
la
bl
e.
A
ll
ex
am
in
at
io
ns
w
er
e
pe
rf
or
m
ed
by
lo
ca
lp
hy
si
ci
an
s
in
Pa
ki
st
an
,a
nd
th
e
ne
ur
ol
og
ic
al
ex
am
in
at
io
ns
w
er
e
vi
de
ot
ap
ed
.
A
ll
re
su
lt
s
w
er
e
re
vi
ew
ed
by
th
e
cl
in
ic
ia
ns
at
th
e
N
at
io
na
l
In
st
it
ut
es
of
H
ea
lt
h
w
ho
ar
e
al
so
co
au
th
or
s
of
th
e
pr
es
en
t
ar
ti
cl
e
(A
.J
.G
.,
R
.C
.C
.,
an
d
A
.G
.)
.
a
A
ll
su
bj
ec
ts
ha
d
no
rm
al
re
fle
xe
s
an
d
am
bu
la
te
d
no
rm
al
ly
du
ri
ng
th
e
ex
am
in
at
io
n.
1318 Am. J. Hum. Genet. 72:1315–1322, 2003
Table 2
Two-Point LOD Scores (at v p 0)
MARKER
LOD SCORE IN FAMILYa
PKDF10 PKDF71 PKSR14
D6S1282  1.47 1.08
D6S1619 4.84 4.03 .98
D6S1681 3.16 3.01 .92
D6S406 6.44 4.22 .38
D6S1659 6.53 3.90 1.23
D6S1031 4.67 2.05 1.02
D6S1589 6.99 2.27 .18
D6S286 6.44 1.63 .34
D6S460 5.35 1.35 .41
a LOD scores were calculated using param-
eters described elsewhere (Ahmed et al. 2001;
Bork et al. 2001).
Figure 2 MYO6 mutations segregating in three Pakistani families. Left, Electropherograms of amplimers from genomic DNA templates,
illustrating homozygosity for a single-base-pair insertion mutation in an affected individual, heterozygosity in an obligate carrier, and homozygosity
for the wild-type allele in an unaffected individual from family PKDF10. An arrow indicates the site of the 36-37insT in the second exon. Center,
Electropherograms illustrating genotypes of a homozygous wild-type allele, a 3496CrT heterozygote, and a person homozygous for 3496CrT of
family PKDF71. Right, Electropherograms are shown for transversion mutation 647ArT, a carrier, and the wild-type allele of family PKSR14. All
the mutations described here are numbered from start codon ATG (GenBank accession number AB002387).
1). This interval includes MYO6 (GenBank accession
number AB002387), which encodes unconventional my-
osin VI.
We screened for mutations inMYO6 by sequencing the
1 noncoding and 32 coding exons in the affected indi-
viduals from families PKDF10, PKDF71, and PKSR14.
All exons were amplified by PCR from genomic DNA in
a 20-ml reaction volume. Primers were designed to flank
all of the exon-intron boundaries (see appendix A, table
A1). PCR amplification, sequencing reactions, and mu-
tational analyses were performed as described elsewhere
(Ahmed et al. 2001). In all affected individuals of family
PKDF10, we found a homozygous single-base-pair inser-
tion (36-37insT) in the second exon of MYO6 (fig. 2).
This insertion is predicted to cause a frameshift and pre-
mature translation termination after the first 12 amino
acids of myosin VI. In family PKDF71, affected individ-
uals are homozygous for a transitionmutation, 3496CrT
Reports 1319
Figure 3 A drawing of myosin VI, showing the locations of the mutations causing deafness in humans and mice. The three mutant alleles
reported in this study are shown in bold letters, whereas C442Y and 2456-2585del are from the studies by Melchionda et al. (2001) and
Avraham et al. (1995), respectively. Shown also is the predicted stop codon after twelve out-of-frame amino acids due to 36-37insT.
Figure 4 Alignment of a portion of myosin VI proteins from various species, showing conservation of the glutamate residue at position
216 in the motor domain among seven myosin VI proteins from Homo sapiens, Mus musculus, Rana catesbeiana, Sus scrofa, Gallus gallus,
Morone saxatilis, and Strongylocentrotus. The conserved amino acids are shown with dark gray background, similar amino acids are shown
with a light gray background, and the nonconserved amino acids are shown with a white background.
(fig. 2), resulting in a nonsense codon (R1166X) in exon
32, which encodes part of the globular domain of the tail
region (fig. 3). These two mutations were not found in
100 ethnically matched control DNA samples from
Pakistan.
The single affected individual in family PKSR14 is
homozygous for a missense mutation (E216V) in the
motor domain of myosin VI caused by a transversion
mutation, 647ArT (fig. 2). The E216V mutation sub-
stitutes a valine (nonpolar) for glutamate (polar, nega-
tively charged). This glutamate residue is conserved in
myosin VI proteins from human, mouse, chicken, pig,
striped bass, and sea urchin (fig. 4). In Caenorhabditis
elegans myosin VI, there is an aspartate residue (also
polar, negatively charged) at this position, but Dro-
sophila melanogaster myosin VI has a nonpolar amino
acid (alanine) at this position. The 647ArT transversion
segregating in family PKSR14 was not found among 270
normal representative DNA samples (540 chromosomes)
from the same ethnic group or from the 81 DNA samples
(162 chromosomes) of a Human Diversity panel (Coriell
Cell Repositories).
Myosins are motor proteins that hydrolyze ATP and
translocate along actin filaments (Sellers 1999; Berg et
al. 2001). Mutations of myosins IIA, IIIA, VIIA, and
XVA are associated with hearing loss in humans (Gibson
et al. 1995; Weil et al. 1995; Liu et al. 1997a, 1997b;
Probst et al. 1998;Wang et al. 1998; Lalwani et al. 2000;
Liburd et al. 2001; Walsh et al. 2002). Unlike these other
actin-based motors, myosin VI moves toward the minus
end of F-actin filaments (Wells et al. 1999; Nishikawa
et al. 2002). Myosin VI is involved in many processes,
including membrane trafficking, recycling, cell move-
ment, and endocytosis (Mermall and Miller 1995; Bohr-
mann 1997; Mermall et al. 1998; Buss et al. 2001; Mor-
ris et al. 2002). In the inner and outer hair cells of the
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organ of Corti, myosin VI is highly expressed at the base
of stereocilia rootlets and in the pericuticular necklace
(Avraham et al. 1997; Hasson et al. 1997; Self et al.
1999).
Myosin VI is abundantly expressed in the retina (Breck-
ler et al. 2000), and it has been speculated that mutations
of MYO6 might cause RP (Ahituv et al. 2000). Interest-
ingly, one hearing-impaired individual (IV:19, age 10
years; table 1) among the families with DFNB37 was
found to have RP. No ocular abnormalities were detected
in the older deaf individuals, and electroretinography re-
sults were normal among the other eight affected indi-
viduals (aged 9–21 years) from the three families with
DFNB37.We cannot rule out the possibility of an atypical
Usher syndrome in family PKDF10, since most of the
affected individuals are too young to exhibit the ocular
phenotype or there could be a modifier altering the effect
of a null mutation in retina. In addition to deafness in
family PKDF10, vestibular dysfunction and mild facial
dysmorphology also occur, but not in all of the deaf in-
dividuals (table 1). Late ambulation, which may or may
not be related to a vestibular dysfunction, was also found
in individual IV:23 (table 1), who has normal hearing and
is a noncarrier of the MYO6 mutant allele. The small
sample size makes it difficult to determine whether there
is reduced penetrance for these and other clinical findings
that can be attributed to a null mutation of MYO6.
Two recessive putative null mutations of mouseMyo6
are responsible for deafness and vestibular dysfunction
in Snell’s waltzer mice (Avraham et al. 1995), and a
missense allele (C422Y) of MYO6 cosegregates with
nonsyndromic, dominantly inherited, progressive hear-
ing loss in a single family that defined theDFNA22 locus
(MIM 606346) (Melchionda et al. 2001). The predicted
structural motifs and the known, postulated mutant al-
leles of myosin VI that are associated with hearing loss
are shown in figure 3. Since the DFNB37 alleles appear
to be functional null alleles and since the heterozygous
carriers of DFNB37 mutations of MYO6 have normal
hearing, the putative DFNA22 mutation likely acts via
a dominant-negative or gain-of-function mechanism.
There is a possibility that two missense substitutions
(C422Y and E216V) found inMYO6may have nothing
to do with hearing loss and may be in linkage disequi-
librium with actual mutations. Biophysical measure-
ments, such as a motility assay with these substitutions
in the motor domain ofMYO6, may help to address the
pathogenic potential, if any exists. Nevertheless, two of
the DFNB37 alleles (36-37insT and R1166X) reported
herein constitute convincing genetic evidence that dis-
ablement ofMYO6 causes recessively inherited deafness
in humans.
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Appendix A
Table A1
MYO6 Intronic Primer Pairs Flanking Known Exons
EXON
PRIMER
(5′r3′)
PRODUCT
LENGTH
(bp)Forward Reverse
1 aac aag aac tcc cgg ctt gt cat cca tca cct gct tct cc 589
2 ggc aga tgt gtt tgt tag ttg g cct agg gca cat acc tct gat t 452
3 tat gca acc aat taa gcc ctt c ttc tga acc cgc aca gtg tat 253
4 agg atg agt caa agt gat tca ga tct att caa gag gct cag atc aa 291
5 gga ctg att tgg gag tct tag tt cca aga ggt ata cag ttt ctc caa 391
6 tga ttt ctt taa gag taa gtg gtc ct aga atg agg tgg aac agt gg 364
7 tga tga tct agg ttt cag ttt tat atg aag aga gtc ttt tgc atc tct ga 258
8 tgg aga tat acc atg cat att ttg tcc tgc aac cat cta aag taa ca 303
9 aac ctc ttt gat aga caa atg gta tt aag tat tag gct tga tgg caa tta t 651
10 tct tca tgg ttg gca cta ttt g gtt aga act ctt act tgg gct cta aaa 279
11 agt gca tta att gac ctg gtg t cat tct tca ttt ggg aga ttc a 423
(continued)
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Table A1 (continued)
EXON
PRIMER
(5′r3′)
PRODUCT
LENGTH
(bp)Forward Reverse
12 aag cct tgc cta tta tat ggt ttt t cca agc tca ggt ttt aaa cag aa 352
13 tgt gcc tat tct cac atg acc t cat caa gta aaa tga gtt aca aag gag 394
14 gcc att att aca att aca ttt tat cct ctt ccg tta tac acc atc cat c 293
15 gtt cag aaa cag tgc aaa att ca gca cag aaa aag cac taa aca ca 218
16 tga tca gtc ctt gaa atc tgt ga tgc acc ttt tta ata atg tct cgt 286
17 tga aaa gtg tga aaa ttt cct gt aat aac cac gtg aaa taa tta ata acc 320
18 gga gaa aac cat ttc atg ttg a ggg tct gct ctt gaa ctt cac t 585
19 cac tgt gta ctt tgg ctt ttt ga tgc cat gtc tgg aga atg tta c 442
20 tgc ttt gaa agt tgc agg tat t tgc act gta aaa taa tca aga taa tgg 289
21 ttt tgg act tcc gaa cag tga t caa agc ttt aaa caa agc ctg aa 295
22 tat aaa tgc cac cca aat tga a tgt tgt tag tga cca tat aat tca aga 289
23 ttg aca tgt gac cat ttt cag ac caa cac tcc aca aac cat ctt g 313
24 ttg agc att act ttg tga aaa tga gaa aac ctg agt atc caa act gc 286
25 gaa gtg aaa tac cct gtt tag ca ttt gaa aaa cta agg acg ttt tct 346
26 ttt tgc tgt att tgc ata ttg ga aaa atc gat tga acc cga gag 575
27 ctt ctg aag gat tct tta ttt tct gtt cca tgt ccg gct aat ttg tt 328
28 aag ggg agt gat caa gta aac aa tca ttc act tga gta tga aag tcg 398
29 aac aca aat ttg cac aat cca g cca atg aga aaa cta ctc cca aa 176
30 tgt gtt acg gct aga ttt gtt ga cat gta aca ggt tct ggt cca a 308
31 gca tgc ttt ctt gcc tct tta g cat aac tat gtg gga tcc tct gg 450
32 aaa aat ctc ctt atg cga cag aat tgg gac att tta ccc atg tct t 314
33 act ttt cag tca cca cct cga t cca ctg aaa att gta gca aaa ca 238
34 tta cta tta ggg acc ttt ctt ctt ttt ccc tca acc ctg aaa tgt aat a 446
35a aat agg tat ttc agg cat aca act g tag tct tct ggc aaa gga tga g 568
35b cat cct ttg cca gaa gac tac c gaa aca act tgg aca aga ttc tga 619
35c ggc ata gtg gct taa ctg gac t caa aca cta gtc agc tgg gaa a 554
NOTE.—Primers were designed through use of the Primer3 Web-Based Server.
Electronic-Database Information
The accession number and URLs for data presented herein
are as follows:
Center for Medical Genetics, Marshfield Medical Research
Foundation, http://research.marshfieldclinic.org/genetics/
Hereditary Hearing Loss Homepage, http://www.uia.ac.be/
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GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (forMYO6
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